Home | Back to newsletter main page
|
| |
![]() |
|
January 28, 2013 |
|
CASE CCC IN THE NEWSResearchers Discover Promising Prognostic Marker for Aggressive Breast Cancer First Harrington Distinguished Scholar Brings Breast Cancer Research to Cleveland Collaboration in academia designed to increase return on research investments Cleveland Clinic Opens Wig and Cap Boutique for its Cancer Patients Highlights From the 2013 Gastrointestinal Symposium, with Neal Meropol, MD Drug Is Shown to Help Pancreatic Cancer Cases ANNOUNCEMENTSMiltenyi Biotec to Contribute Portion of Purchases to Support TRCCC ConferenceMiltenyi Biotec is offering special discounts in relation to the upcoming TRCCC conference. Special offers include:
Click here for more information. FUNDING OPPORTUNITIES/AWARDSAmerican Cancer Society IRG AwardsThe Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs. LOI Deadline: February 18 Alex's Lemonade Stand Foundation Pediatric Oncology Student Training ProgramAlex's Lemonade Stand Foundation (ALSF) is dedicated to funding pediatric oncology researchers at critical points in their careers. The Pediatric Oncology Student Training (POST) Program is designed for graduate and medical students who have an interest in pediatric oncology research and would like to experience the field first hand. Students train with a pediatric oncology research mentor. Students may join a research project underway in a mentor's lab or begin an original investigation with the mentor. Deadline: March 4 MARK YOUR CALENDARSGrant Writing WorkshopsThe CWRU Office of Research Administration is pleased to announce that Dr. Bob Lucas, Director of the Institute for Scholarly Productivity in San Luis Obispo, California, will be on campus to present two grant writing workshops: Scholarly Writing Introduction to Proposal Writing Register today! TRCCC Annual Meeting: The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor ImmunityRegistration is open for the 16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC), The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity. Held February 20-22 at the Seven Springs Mountain Resort in Seven Springs, PA, this meeting will feature two symposiums focused on Tumor-mediated Immune Suppression and Vaccine and Cellular Therapy, with spotlight sessions on Imaging and Viral Vectors. The agenda will also include a poster session. Researchers, institutional officials, and students are invited to submit abstracts for poster presentations by February 4. | EVENTS
January 28Pathology Research Seminar Series January 29Radiation Oncology Grand Rounds Immunology Seminar Series Medicine Grand Rounds January 30Hematology and Oncology Division Research Conference January 31
February 1Hematology/Oncology Fellows Conference/Curriculum Series Taussig Cancer Institute Grand Rounds Engineering and Medicine Seminar Cancer Center Seminar Series Molecular Biology and Microbiology Thesis Presentation Cancer Center Research in Progress
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSThe Role of Interferon in Metastasis and Resistance to DNA Damage in Prostate Cancer IMPACT: Improving Sickle Cell Patient Adherence Through Collaborative Teaching Breast Cancer Conference
ADDITIONAL UPCOMING SEMINARS & EVENTS16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRC3): The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity National GvHD Health Symposium |
|
|
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES |
|
|
Sarcoma Foundation of America |
Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC) |
|
|
|
NIH BULLETIN – Notices and Funding Opportunities |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216.844.8317 phone 216.844.7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|